Metabolic network expression in parkinsonism: Clinical and dopaminergic correlations
Authors:
- 21 July 2016
- journal article
- research article
- Published by SAGE Publications in Journal of Cerebral Blood Flow & Metabolism
- Vol. 37 (2) , 683-693
Abstract
Little is known of the precise relationship between the expression of disease-related metabolic patterns and nigrostriatal dopaminergic dysfunction in parkinsonism. We studied 51 subjects with Parkinson's disease (PD) (18 non-demented, 24 demented, and 9 dementia with Lewy bodies) and 127 with atypical parkinsonian syndromes (47 multiple system atrophy (MSA), 38 progressive supranuclear palsy (PSP), and 42 corticobasal syndrome (CBS)) with 18F-fluorodeoxyglucose PET to quantify the expression of previously validated disease-related patterns for PD, MSA, PSP, and CBS and 18F-fluoropropyl-β-CIT PET to quantify caudate and putamen dopamine transporter (DAT) binding. The patients in each group exhibited significant elevations in the expression of the corresponding disease-related pattern ( p < 0.001), relative to 16 healthy subjects. With the exception of cerebellar MSA (MSA-C), all groups displayed significant reductions in putamen DAT binding relative to healthy subjects ( p < 0.05). Correlations between the dopaminergic and metabolic measures were significant in PD and CBS but not in MSA and PSP. In all patient groups with the exception of MSA-C and CBS, pattern expression values and DAT binding correlated with disease duration and severity measures. The findings suggest that in these parkinsonian disorders, metabolic network expression and DAT binding provide complementary information regarding the underlying disease process.Keywords
This publication has 40 references indexed in Scilit:
- Network correlates of disease severity in multiple system atrophyNeurology, 2012
- Subregional Patterns of Preferential Striatal Dopamine Transporter Loss Differ in Parkinson Disease, Progressive Supranuclear Palsy, and Multiple-System AtrophyJournal of Nuclear Medicine, 2012
- Scaled subprofile modeling of resting state imaging data in Parkinson's disease: Methodological issuesNeuroImage, 2011
- Metabolic brain networks in neurodegenerative disorders: a functional imaging approachTrends in Neurosciences, 2009
- Second consensus statement on the diagnosis of multiple system atrophyNeurology, 2008
- Abnormal metabolic networks in atypical parkinsonismMovement Disorders, 2008
- Deep brain stimulation for the treatment of atypical parkinsonismMovement Disorders, 2007
- The metabolic landscape of cortico-basal ganglionic degeneration: regional asymmetries studied with positron emission tomography.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- THE RELATIONSHIP BETWEEN LOCOMOTOR DISABILITY, AUTONOMIC DYSFUNCTION, AND THE INTEGRITY OF THE STRIATAL DOPAMINERGIC SYSTEM IN PATIENTS WITH MULTIPLE SYSTEM ATROPHY, PURE AUTONOMIC FAILURE, AND PARKINSON'S DISEASE, STUDIED WITH PETBrain, 1990
- “Mini-mental state”Journal of Psychiatric Research, 1975